Psilocybin could receive FDA approval by late 2026 following a Trump executive order and priority review vouchers. Here’s what the evidence shows and what it means for patients.
Psilocybin Could Become the First FDA-Approved Psychedelic Therapy Within Months — Here Is What Patients Need to Know
by | Jun 28, 2026 | Uncategorized | 0 comments
Recent Comments